Myeloid-derived suppressor cells (MDSCs) have been described as suppressors of T-cell function in many malignancies. Impaired T-cell responses have been observed in patients with chronic hepatitis C virus infection (CHC), which is reportedly associated with the establishment of persistent HCV infection. Therefore, we hypothesized that MDSCs also play a role in chronic HCV infection. MDSCs in the peripheral blood of 206 patients with CHC and 20 healthy donors were analyzed by flow cytometry.
| INTRODUC TI ON
Chronic hepatitis C (CHC) is a serious global health problem and more than 185 million individuals are estimated to be infected with the hepatitis C virus (HCV) globally. 1 CHC is a potential cause of liver cirrhosis and hepatocellular carcinoma. 2 Impairment of host immunity, especially the loss of HCV-specific cellular immune response, may lead to chronic infection. 3 HCV-specific CD4 + and CD8 + T cells exhibit various degrees of functional impairment including impaired proliferation of T-cells and reduced effector cytokine production. 4 However, the precise mechanisms underlying HCV-mediated T-cell immune attenuation are not completely understood.
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid precursor cells and have been reported to play important roles in the development of microbial inflammation, infection, autoimmune disorders and cancer. 5, 6 Furthermore, enhanced accumulation of MDSCs has been observed in mice with chronic but not acute infection with different strains of lymphocytic choriomeningitis virus. 7 Vollbrecht et al 8 reported
that MDSCs inhibited T-cell proliferation and were associated with disease progression in HIV-1-infected individuals. An increased frequency of MDSCs has also been described in the context of chronic hepatitis B virus infections, and these cells have been shown to suppress the antiviral activities of CD8 + T cells. 9 HBV-associated impairment of T-cell activation is also correlated with the accumulation of MDSCs, which have been implicated in stimulating the hepatitis B surface antigen (Ag). 9 Recent reports showed that HCV promotes MDSC accumulation, which facilitates and maintains the persistent HCV infection. 10 A higher percentage of MDSCs, defined as CD33 + HLA-DR −/low CD11b + , has been detected in the peripheral blood of CHC patients compared with that of healthy control subjects. These cells have been shown to suppress HCV-specific CD8 + T cell responses. 10 However, the mechanisms involved in the expansion of MDSCs in patients with CHC have not been identified.
HCV core protein (HCVc; 21 kDa) is secreted from HCV-infected hepatocytes and is extracellularly present in the plasma of chronically infected patients. 11 The extracellular core exerts an immunomodulatory role in human monocytes, macrophages and dendritic cells resulting in the inhibition of toll-like receptor-induced proinflammatory cytokine production including IFN-α and IL-10. 12 Furthermore, HCVc activates a signal transducer that is critical for the development of regulatory APCs. 10 Because the induction of HCVc-specific T-cell responses is inversely correlated with the serum HCVc concentration, 13 we hypothesized that the high concentration of circulating
HCVc found during HCV infection may facilitate the development of MDSCs and be responsible for the attenuation of HCV-specific T-cell responses, leading to HCV persistence. 14 Therefore, this study aimed to examine the possible involvement and mechanism of HCVc in MDSC expansion and T-cell suppression in patients with CHC.
| MATERIAL AND ME THODS

| Ethics statement
Ethical approval was obtained from the Human Research Ethics
Committee (the First Affiliated Hospital of Zhengzhou University, China). Written informed consent was obtained from all participants.
| Statistical analysis
Statistical analysis was performed using the SPSS software (version 16.0; SPSS Inc., Chicago, IL, USA) and GraphPad Prism software (version 5.0; San Diego, CA, USA). Categorical data were expressed as numbers or proportions of subjects with the specific features. The chi-square test or Fisher's exact probability test was used to compare categorical data. Normally distributed continuous variables were summarized as mean ± standard deviation (SD), and one-way ANOVA was used to compare the difference between two groups. Continuous variables not normally distributed were summarized as medians and ranges, and the nonparametric Mann-Whitney U test was used to compare the difference between two groups. The Kruskal-Wallis H test was used for the comparison of differences among three or more groups and further comparisons between any two groups within these multiple groups were conducted using the Nemenyi method.
Correlations between variables were calculated using the Spearman rank order correlation. All P values were two-sided. P values < 0.05
were considered as statistically significant in all cases.
| RE SULTS
| Correlations between myeloid-derived suppressor cells and clinicopathological parameters
In total, 206 treatment-naive CHC patients and 20 healthy donors were enrolled in this study. The complete study process is summarized in Figure S1 . By the end of the study, 180 CHC patients were evaluable for analysis. The clinicopathological parameters of 180 CHC patients and 20 healthy donors are listed in Table S1 . 
| Myeloid-derived suppressor cells inhibit Tcell responses
Myeloid-derived suppressor cells are known to suppress immune responses in a variety of ways in different kinds of malignancies. 16, 17 We wanted to confirm whether MDSCs in the peripheral blood of CHC patients can suppress T-cell function.
PBMCs harvested from CHC patients (n = 12) with or without MDSC depletion (MDSCs were depleted by cell sorting using flow cytometry) were stimulated with anti-CD3/CD28 antibodies and T-cell proliferation was measured by CFSE (5, 6 carboxyfluorescein diacetate, succinimidyl ester) dilution after a 3-day culture.
We observed a consistent enhancement of both CD4 + and CD8 
| Hepatitis C virus core protein promotes the differentiation of granulocytic myeloid-derived suppressor cells from PBMCs
To determine the effects of HCVc on the differentiation of MDSCs, PBMCs obtained from healthy donors were cultured with Figure 6D ). Cytokines including Arg-1, COX-2, iNOS and IL-2 were confirmed to have no effect on the production of MDSCs. 9 So, we speculated that the secretion of the cytokine IL-10, which is induced by HCVc, might lead to the polarization of G-MDSCs.
To investigate the molecular mechanism of IL-10 production in HCVc-induced MDSCs, we examined ERK1/2 MAPK which has been shown to regulate the production of certain cytokines such as IL-6 and IL-10 in PBMCs. 9, 18 We therefore evaluated the phosphorylation of ERK1/2. As shown in Figure 6E , stimulation of PBMCs with HCVc induced ERK1/2 phosphorylation in a dose-dependent manner.
Moreover, the ERK1/2-specific inhibitor PD98059 completely inhibited the polarization of G-MDSCs by HCVc ( Figure 6E ) and attenuated IL-10 production to basal levels ( Figure 6F ). These results show that HCVcmediated activation of ERK1/2 plays a role in the production of IL-10. 
| Myeloid-derived suppressor cells correlated with prognosis in chronic hepatitis C patients as an independent predictor
To screen the possible predictive factors of SVR, we analyzed the correlations between clinicopathological parameters and the outcomes of 180 CHC patients. Single variable logistic regression analysis revealed that the predictive factors of SVR included age, ALT, AST, ALB, serum HCV-RNA, HCVc, HCV genotype, HLA-A*02, LSM, RVR and G-MDSCs (Table 1A) . These significant variables were put into the multivariate logistic regression model to identify the independent predictive factors of SVR, and we found that G-MDSCs were one of the independent predictors of SVR (Table 1B) . Moreover, we evaluated the predictive precision of G-MDSCs for SVR by ROC analysis.
As shown in Table S2 and Figure 
| D ISCUSS I ON
Many studies have demonstrated that MDSCs are significantly increased in malignancies, autoimmune disease and viral infectious which is in line with a prior report. 10 It is known that HCV infection can lead to inflammation in the liver and the secretion of inflammatory cytokines, which may result in damage to hepatocytes and the release of ALT in the blood. 32 Chronic HCV infection activates
Kupffer cells, macrophages and dendritic cells, and these lead to a dysfunction in the immune system which promotes hepatic fibrosis. 33 In this study, we found that the frequency of G-MDSCs is positively correlated with the levels of ALT and LSM which reflect liver injury, and these results were in agreement with the report conducted by Cai et al. 14 A prior study found that the proliferation and IFN-γ secretion of CD4 + and CD8 + T cells in the peripheral blood of CHC patients were inhibited by MDSCs. 10 In this study, production was increased in the supernatants of HCVc-polarized TA B L E 1 (A) The clinicopathological parameters of CHC patients were associated with the probability of SVR. (B) Analysis of possible predictors for SVR of HCV patients by using multiple variables binary logistic regression model HCVc-induced differentiation of G-MDSCs. In conclusion, our results show a complex mechanism involving a regulatory pathway and two independent signal transduction pathways essential for
HCVc-mediated polarization of G-MDSCs.
Myeloid-derived suppressor cells have been associated with disease progression, drug resistance, tumour recurrence, and metastasis. 17 Many studies have found that expansion of MDSCs is correlated with reduced survival rate in patients with malignancy. 45 Moreover, the prognostic significance of G-MDSC accumulation has also been reported in melanoma, 46 hepatocellular carcinoma, 30 as well as non-small lung cancer. 47 However, the prognostic significance of MDSC accumulation in CHC patients treated with antiviral therapy has not been clear. In this study, we found that the frequency of G-MDSCs was associated with negative prognosis in CHC patients treated with standard antiviral therapy. Accumulation of G-MDSCs is one of the independent predictive factors of SVR in CHC patients. By using ROC analysis, we found that G-MDSCs had higher areas under ROC curve, sensitivity, specificity, Youden index, PPV and NPV, and could effectively enhance the predictive accuracy of SVR in CHC patients. These results indicated that the frequency of circulatory G-MDSCs may be a promising biomarker to predict the prognosis of CHC patients receiving standard antiviral therapy.
In conclusion, our study demonstrates that HCVc maintains HCV persistence and immunosuppression by promoting IL-10/ STAT3-dependent differentiation of G-MDSCs from PBMCs, resulting in impaired T-cell function. We also suggest that G-MDSCs may be a promising biomarker for predicting the prognosis of CHC patients.
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